Influenza

Showing NaN - NaN of 88

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)

Not yet recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1083
  • +3 more
  • Anniston, Alabama
  • +172 more
Oct 18, 2023

SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)

Recruiting
  • SARS-CoV-2
  • Influenza
  • Fluarix
  • +8 more
  • Chandler, Arizona
  • +68 more
Apr 24, 2023

COVID-19, Influenza Trial in Rochester (GRIP Electronic Diagnostic Chip, Laboratory-based nucleic acid amplification tests

Not yet recruiting
  • COVID-19
  • Influenza
  • GRIP Electronic Diagnostic Chip
  • Laboratory-based nucleic acid amplification tests (NAATs)
  • Rochester, Minnesota
    Mayo Clinic Minnesota
Dec 21, 2022

SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

Active, not recruiting
  • SARS-CoV-2
  • Influenza
  • mRNA-1073
  • +3 more
  • Hollywood, Florida
  • +13 more
Oct 5, 2022

Influenza Trial in Hollywood, Rochester, Mount Pleasant (Quadrivalent RIV with H3 strain 1, Quadrivalent RIV with H3 strain 2,

Completed
  • Influenza
  • Quadrivalent RIV with H3 strain 1
  • +4 more
  • Hollywood, Florida
  • +2 more
Apr 21, 2022

Influenza Trial in United States (QIV-HD, Licensed TIV-HD1, Investigational TIV-HD2)

Completed
  • Influenza
  • QIV-HD
  • +2 more
  • Anaheim, California
  • +35 more
Mar 24, 2022

Influenza Trial in United States (FluBlok®, Placebo)

Completed
  • Influenza
  • FluBlok®
  • Placebo
  • Beverly Hills, California
  • +23 more
Mar 24, 2022

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Recruiting
  • Influenza
  • +2 more
    • San Diego, California
    • +62 more
    Mar 28, 2022

    Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)

    Completed
    • Influenza
    • Influenza Immunisation
    • Influenza Virus Quadrivalent Inactivated Vaccine
    • Rochester, New York
      University of Rochester Medical Center - Strong Memorial Hospita
    Mar 17, 2022

    Influenza Trial in Rochester (Fluad Vaccine, Fluzone High-Dose)

    Active, not recruiting
    • Influenza
    • Fluad Vaccine
    • Fluzone High-Dose
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 22, 2021

    Influenza Trial in Rochester (FluBlok, Fluzone, FluCelVax)

    Completed
    • Influenza
    • FluBlok
    • +3 more
    • Rochester, New York
      University of Rochester Medical Center, Vaccine Research Unit Ro
    Nov 1, 2021

    HIV, Influenza Trial in Puerto Rico, United States (Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated

    Completed
    • HIV Infections
    • Influenza
    • Cold-adapted live attenuated influenza vaccine (FluMist)
    • Inactivated influenza vaccine (IAIV)
    • Birmingham, Alabama
    • +60 more
    Oct 28, 2021

    Influenza Trial in Worldwide (Liquid CAIV-T)

    Completed
    • Influenza
    • Liquid CAIV-T
    • Hoover, Alabama
    • +160 more
    Sep 10, 2021

    Influenza Trial in Rochester (Seasonal IIV 0.25 mL dose, Natural influenza infection, Seasonal IIV 0.5 mL dose)

    Completed
    • Influenza
    • Seasonal IIV 0.25 mL dose
    • +2 more
    • Rochester, New York
      University of Rochester
    Aug 5, 2021

    Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)

    Completed
    • Influenza
    • Influenza Immunisation
    • Influenza Virus Quadrivalent Inactivated Vaccine
    • Rochester, New York
    • +1 more
    Apr 29, 2021

    Bird Flu, Influenza Trial in United States (Placebo, Ad4-H5-Vtn, Sanofi Pasteur Influenza Virus Vaccine, H5N1)

    Completed
    • Bird Flu
    • Influenza
    • Placebo
    • +2 more
    • Lexington, Kentucky
    • +3 more
    Mar 16, 2020

    Influenza Trial in Rochester (H7N3 pLAIV, H7N9 pIIV)

    Completed
    • Influenza
    • H7N3 pLAIV
    • H7N9 pIIV
    • Rochester, New York
      University of Rochester Medical Center Vaccine Research Unit (Ou
    Mar 22, 2019

    Influenza Trial in Worldwide (Amantadine, Ribavirin, Oseltamivir, Oseltamivir)

    Completed
    • Influenza
    • Birmingham, Alabama
    • +90 more
    Jan 31, 2019

    Influenza Trial in Worldwide (GSK Bio's influenza vaccine GSK2186877A, Fluarix TM)

    Completed
    • Influenza
    • GSK Bio's influenza vaccine GSK2186877A
    • Fluarix TM
    • Alabaster, Alabama
    • +273 more
    May 8, 2018

    Influenza Trial in United States (Fluarix™, Fluzone)

    Completed
    • Influenza
    • Fluarix™
    • Fluzone
    • Antioch, California
    • +39 more
    May 8, 2018

    Influenza Trial in Canada, United States (Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Placebo)

    Completed
    • Influenza
    • Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
    • Placebo
    • Huntsville, Alabama
    • +39 more
    May 9, 2018

    Influenza Trial in Worldwide (Influsplit Tetra™ vaccine produced by investigational process (IP), Influsplit Tetra™ vaccine

    Completed
    • Influenza
    • Influsplit Tetra™ vaccine produced by investigational process (IP)
    • Influsplit Tetra™ vaccine produced by licensed process (LP)
    • Wichita, Kansas
    • +52 more
    May 31, 2018

    Influenza Trial in United States (CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine

    Completed
    • Influenza
    • CSL Limited Influenza Virus Vaccine (Afluria®)
    • US Licensed Influenza Virus Vaccine (Fluzone®)
    • Mountain Home, Arkansas
    • +12 more
    Apr 25, 2018

    Influenza Trial in Rochester (H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV), H3N2v inactivated subvirion

    Terminated
    • Influenza
    • H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV)
    • +2 more
    • Rochester, New York
      University of Rochester Medical Center (URMC), Vaccine Research
    May 1, 2018

    Influenza Trial in Worldwide (Nitazoxanide, Oseltamivir, Placebo Oral Tablet)

    Completed
    • Influenza
    • Birmingham, Alabama
    • +166 more
    Mar 27, 2018